Effect of UGT2B10, UGT2B17, FMO3, and OCT2 genetic variation on nicotine and cotinine pharmacokinetics and smoking in African Americans

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Pharmacogenetics & Genomics

• Publication date

  2017-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/FPC.0000000000000269PMID 28178031PMCID PMC5346034
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Genome-Wide Meta-Analysis of Cotinine Levels in Cigarette Smokers Identifies Locus at 4q13.2

  2016cited by this paper
• Disposition kinetics and metabolism of nicotine and cotinine in African American smokers: impact of CYP2A6 genetic variation and enzymatic activity

  2016cited by this paper
• A UGT2B10 Splicing Polymorphism Common in African Populations May Greatly Increase Drug Exposure

  2015cited by this paper
• Nicotine N-glucuronidation relative to N-oxidation and C-oxidation and UGT2B10 genotype in five ethnic/racial groups.

  2014cited by this paper
• Novel CYP2A6 variants identified in African Americans are associated with slow nicotine metabolism in vitro and in vivo

  2014cited by this paper
• UGT1A and UGT2B Genetic Variation Alters Nicotine and Nitrosamine Glucuronidation in European and African American Smokers

  2014cited by this paper
• Organic cation transporter variation and response to smoking cessation therapies.

  2014cited by this paper
• The Contribution of Common Genetic Variation to Nicotine and Cotinine Glucuronidation in Multiple Ethnic/Racial Populations

  2014cited by this paper
• N-acetyltransferase 1 polymorphism increases cotinine levels in Caucasian children exposed to secondhand smoke: the CCAAPS birth cohort

  2014cited by this paper
• Association of CHRNA5-A3-B4 SNP rs2036527 with smoking cessation therapy response in African American smokers

  2014cited by this paper
• CYP2A6 slow nicotine metabolism is associated with increased quitting by adolescent smokers

  2013cited by this paper
• The Ability of Plasma Cotinine to Predict Nicotine and Carcinogen Exposure is Altered by Differences in CYP2A6: the Influence of Genetics, Race, and Sex

  2013cited by this paper
• The contribution of common UGT2B10 and CYP2A6 alleles to variation in nicotine glucuronidation among European Americans

  2013cited by this paper
• Effects upon in-vivo nicotine metabolism reveal functional variation in FMO3 associated with cigarette consumption

  2013cited by this paper
• Reproducibility of the Nicotine Metabolite Ratio in Cigarette Smokers

  2012cited by this paper
• PharmGKB summary: very important pharmacogene information for cytochrome P-450, family 2, subfamily A, polypeptide 6

  2012cited by this paper
• Effects of genetic variants in SLC22A2 organic cation transporter 2 and SLC47A1 multidrug and toxin extrusion 1 transporter on cisplatin-induced adverse events

  2012cited by this paper
• Glucuronidation of trans-3′-hydroxycotinine by UGT2B17 and UGT2B10

  2012cited by this paper
• Relationship between CYP2A6 and CHRNA5-CHRNA3-CHRNB4 variation and smoking behaviors and lung cancer risk.

  2011cited by this paper
• Is 24h nicotine equivalents a surrogate for smoke exposure based on its relationship with other biomarkers of exposure?

  2011cited by this paper
• Racial/ethnic and socioeconomic variations in duration of smoking: results from 2003, 2006 and 2007 Tobacco Use Supplement of the Current Population Survey.

  2010cited by this paper
• UGT2B10 Genotype Influences Nicotine Glucuronidation, Oxidation, and Consumption

  2010cited by this paper
• A map of human genome variation from population-scale sequencing

  2010cited by this paper
• Glucuronidation genotypes and nicotine metabolic phenotypes: importance of functional UGT2B10 and UGT2B17 polymorphisms.

  2010cited by this paper
• Nicotine Metabolism in African Americans and European Americans: Variation in Glucuronidation by Ethnicity and UGT2B10 Haplotype

  2010cited by this paper
• Nicotine chemistry, metabolism, kinetics and biomarkers.

  2009cited by this paper
• Intermittent and light daily smoking across racial/ethnic groups in the United States.

  2009cited by this paper
• Effect of genetic variation in the organic cation transporter 2 on the renal elimination of metformin

  2009cited by this paper
• Contribution of Organic Cation Transporter 2 (OCT2) to Cisplatin‐Induced Nephrotoxicity

  2009cited by this paper
• A novel CYP2A6 allele (CYP2A6*35) resulting in an amino-acid substitution (Asn438Tyr) is associated with lower CYP2A6 activity in vivo

  2009cited by this paper
• Association of Nicotine Metabolite Ratio and CYP2A6 Genotype With Smoking Cessation Treatment in African‐American Light Smokers

  2009cited by this paper
• Clinical Pharmacology of Nicotine: Implications for Understanding, Preventing, and Treating Tobacco Addiction

  2008cited by this paper
• OCT2 polymorphisms and in-vivo renal functional consequence: studies with metformin and cimetidine

  2008cited by this paper
• Novel and established CYP2A6 alleles impair in vivo nicotine metabolism in a population of Black African descent

  2008cited by this paper
• Glucuronidation of nicotine and cotinine by UGT2B10: loss of function by the UGT2B10 Codon 67 (Asp>Tyr) polymorphism.

  2007cited by this paper
• Genetic polymorphisms of human flavin-containing monooxygenase 3: implications for drug metabolism and clinical perspectives.

  2007cited by this paper
• Ethnic and Racial Differences in the Smoking-Related Risk of Lung Cancer

  2007cited by this paper
• CYP2A6 genotype and the metabolism and disposition kinetics of nicotine

  2006cited by this paper
• Impact of CYP2A6 genotype on pretreatment smoking behaviour and nicotine levels from and usage of nicotine replacement therapy

  2006cited by this paper
• Implications of CYP2A6 Genetic Variation for Smoking Behaviors and Nicotine Dependence

  2005cited by this paper
• Metabolism and Disposition Kinetics of Nicotine

  2005cited by this paper
• Metabolic profile of nicotine in subjects whose CYP2A6 gene is deleted.

  2004cited by this paper
• Ethnic variation in CYP2A6 and association of genetically slow nicotine metabolism and smoking in adult Caucasians.

  2004cited by this paper
• Nicotine metabolite ratio as an index of cytochrome P450 2A6 metabolic activity

  2004cited by this paper
• N-glucuronidation of nicotine and cotinine by human liver microsomes and heterologously expressed UDP-glucuronosyltransferases.

  2003cited by this paper
• Nicotine metabolism and intake in black and white smokers.

  1998cited by this paper
• Functional characteristics and membrane localization of rat multispecific organic cation transporters, OCT1 and OCT2, mediating tubular secretion of cationic drugs.

  1998cited by this paper
• Metabolism of nicotine to cotinine studied by a dual stable isotope method

  1994cited by this paper
• Nicotine metabolic profile in man: comparison of cigarette smoking and transdermal nicotine.

  1994cited by this paper
• Evidence for urinary excretion of glucuronide conjugates of nicotine, cotinine, and trans-3'-hydroxycotinine in smokers.

  1992cited by this paper
• Selected ion monitoring method for determination of nicotine, cotinine and deuterium-labeled analogs: absence of an isotope effect in the clearance of (S)-nicotine-3',3'-d2 in humans.

  1991cited by this paper

• Systematic Review of Naturally Derived Substances That Act as Inhibitors of the Nicotine Metabolizing Enzyme Cytochrome P450 2A6

  2024cites this paper
• Biochemical and genetic biomarkers associated with nicotine dependence in Mexican smokers

  2023cites this paper
• Organic cation transporters in psychiatric and substance use disorders

  2023cites this paper
• Pharmacokinetic interactions between clozapine and valproic acid in patients with treatment-resistant schizophrenia: Does UGT polymorphism affect these drug interactions?

  2022cites this paper
• Impact of Genetic Variants in the Nicotine Metabolism Pathway on Nicotine Metabolite Levels in Smokers

  2022influential citation
• Biochemistry of nicotine metabolism and its relevance to lung cancer

  2021cites this paper
• The Role of Pharmacogenetics in Smoking

  2021cites this paper
• Effect of race and glucuronidation rates on the relationship between nicotine metabolite ratio and nicotine clearance

  2021cites this paper
• Pharmacogenetics factors influencing smoking cessation success; the importance of nicotine metabolism

  2020cites this paper
• Evaluation of a weighted genetic risk score for the prediction of biomarkers of CYP2A6 activity

  2020cites this paper
• Nicotine and Cardiovascular Function

  2020cites this paper
• Genome-wide association meta-analysis of nicotine metabolism and cigarette consumption measures in smokers of European descent

  2020cites this paper
• UGT2B10 Genotype Influences Serum Cotinine Levels and Is a Primary Determinant of Higher Cotinine in African American Smokers

  2020cites this paper
• Bidirectional Associations among Nicotine and Tobacco Smoke, NeuroHIV, and Antiretroviral Therapy

  2019cites this paper
• Factors Affecting Interindividual Variability of Hepatic UGT2B17 Protein Expression Examined Using a Novel Specific Monoclonal Antibody

  2019cites this paper
• Lung cancer health disparities.

  2018cites this paper
• Introductory Chapter: Linkages between Pharmacokinetics and Adverse Effects of Drugs

  2018cites this paper
• Wastewater-based epidemiology in low Human Development Index states: bias in consumption monitoring of illicit drugs

  2018cites this paper